Company
United StatesNational Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD – FDA Inspections
Inspection records and compliance data for National Cancer Institute, Cancer Therapy Evaluation Program in Bethesda, Maryland. 2 FDA inspections on record, last inspected January 10, 2020.
Company Profile
This profile covers National Cancer Institute, Cancer Therapy Evaluation Program based in Bethesda, Maryland, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected July 17, 2014. Last inspected January 10, 2020.
Most cited issue areas
- Financial information - sufficient and accurate1 inspection
- Investigator selection1 inspection
- Investigator statement (FDA 1572)1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 10, 2020 | NAI | Human Drugs · Bioresearch Monitoring | 1118260 |
| July 17, 2014 | VAI | Human Drugs · Bioresearch Monitoring | 891981 |
FDA documents
Form 483s (1)
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
National Cancer Institute, Cancer Therapy Evaluation Program
FEI Number
3010830399
Address
31 Center Dr., Bethesda, Maryland 20892, United States
Country
United States
ID: 8cc7f4d2-3770-43d0-adba-33439499bb74